Up in Smoke: Study Exposes Bad Science Behind Vaping’s Alleged Respiratory Risks

American Vapor Manufacturers Logo

Serial scaremongers in the public health establishment have claimed for years that nicotine vaping can severely damage respiratory health, implausibly arguing that it may even be as harmful as cigarette smoking. It was always a spurious claim, but now the evidence supporting that assertion has gone up in smoke, courtesy of an umbrella review published in the journal Tobacco Use Insights.

No Evidence of Harm

The paper synthesized evidence from 12 systematic reviews to evaluate whether vaping poses serious risks to lung function or respiratory outcomes, revealing “no significant change in respiratory function with [vaping], either with dual use with continued cigarette use, exclusive use after quitting smoking, or naïve use by consumers who have never smoked.” 

Notably, the review found no significant association between vaping and increased risks of chronic obstructive pulmonary disease (COPD), asthma worsening, or other serious respiratory conditions, directly contradicting alarmist assertions amplified by public health campaigns and news reports. 

Junk data everywhere

We need to make an important qualification before drawing any conclusions, however. Many of the previous reviews were based on very poor evidence. For example, one review “combined cross-sectional and longitudinal studies … which limits the ability to establish causal relationships,” the authors wrote of a study they excluded from their analysis. 

Cross-sectional studies take a single snapshot in time, while longitudinal studies follow people for an extended period to draw associations between a health outcome and an exposure, vaping in this case. Putting the results of these divergent studies in the same category actually makes it harder to assess the effects of long-term vaping by distorting the data we have access to. 

An equally serious problem was that many previous studies failed to account for duration and intensity of vaping and smoking, rendering their results all but useless. If you don’t know how many cigarettes somebody smokes and how long they’ve smoked, then you can’t assess their respiratory health with any confidence. 

It can’t be understated how important these conclusions are, because they expose the truly awful science behind the campaign against nicotine vaping. We know from previous well-designed research that switching from combustible cigarettes to vaping drastically reduces the disease risk an individual faces. The fact that these lower-quality studies didn’t detect the same improvements probably means “the smoking history of the participants [is] masking potential changes in test results,” the reviewers added.

Conclusion

The umbrella review strikes a serious blow against the politicized narrative that equates vaping and smoking. The only possible conclusions to draw from this review are as follows: vaping has no impact on respiratory health, which is unlikely; or, more plausibly, the reviewed studies are dreadful and we need better data as soon as possible. 

“For accuracy,” the reviewers concluded, “future studies must conduct their analyses on the specific patterns and frequency of [vaping].” They were more polite than I would have been, but the point remains: most anti-vaping research is warmed-over garbage. We should treat it as such. 

Recent Articles

You’ve chosen to work in a gray area. You sell products that contain cannabis or cannabis-adjacent substances as well as accessories that can be used to consume it. And while that area has become less gray—you can see rays of sunlight peeking through—the skies are still cloudy. THC remains a Schedule 1 substance, even as medical marijuana has migrated to Schedule 3.
Running a cannabis business is notoriously complicated. For dispensaries, complex compliance burdens permeate every facet of the business, from zoning and licensing to marketing and payments. Whether you’ve been in the cannabis space for mere months or multiple decades, you’ve likely run into drawn-out approval processes, supply chain headaches, or constantly changing regulation that makes compliance challenging, not to mention the other micro and macroeconomic factors that plague all small business owners.
Blending traditional values with modernized, energetic branding, Not Ya Son’s Weed falls somewhere between the cannabis days of yore and today’s recreational cannabis boom. Not Ya Son’s Weed offers a variety of products—including pre-rolls, exotic flower, and gummies—that provide much-needed relief without being too overbearing.
The officials came for Lance Alyas once before. In 2023, they caught him in a sting, seized his merchandise, and tossed him in jail. But just seven days later, after he invoked Hawaii's version of a Freedom of Information Act request, the whole case fell apart. Alyas was released without bail, allowed to simply walk out the door. Now, he’s advocating for freedom from Hawaii’s state officials once again. Only this time, it’s not just his own freedom. As the owner of Oahu’s top-rated smoke shops, he’s fighting for everyone’s right to sell hemp products in the Aloha State.
Born Sara Benetowa in Warsaw, Poland, in 1903, Sula Benet may not be an immediately recognizable name in cannabis spaces today, but she should be. While she primarily studied Polish folk customs, Benet became known for her graduate thesis at the University of Warsaw, titled Hashish in Folk Customs and Beliefs. In the paper, she claims that the plant kaneh bosm—which is referenced throughout the Old Testament and Torah and often translated as “calamus”—actually refers to hemp. Benet’s theory remains both significant and highly controversial today, especially as various religious and evangelical groups continue to demonize the plant.
If the United States were ever a country based on strict adherence to the law, those days are long past. The modern game lies in devising methods to circumvent laws. It’s how the rich avoid taxes, the powerful avoid jail, and industries of all kinds bypass regulations. The paradox is that, despite its ubiquity, it’s not easy to stay beyond the reach of the long arm of the law. Well-moneyed, influential organizations still sometimes misjudge the political and legal playing field and have to pay up. The Sacklers (the family behind Purdue Pharma) eventually were bankrupted by the courts for their role in the opioid epidemic, and officials hit Meta with a $5 billion fine over privacy concerns.
When you walk into a smoke shop today, you might notice the glass cases that once held rolling papers and blunt wraps now display CBD tinctures, functional mushroom capsules, kava elixirs, and hemp-infused sparkling water. The staff might talk to you about terpene profiles, cortisol levels, and a new vape line.
I went home and told my girlfriend, who, after Googling the name of the business I bought it from, told me that, yes, it was technically weed. But it was CBD. She started laughing, telling me I had been ripped off.